Mendra
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
$82M Series A ·
Led by 5AM Ventures · Source: BioXconomy
Funding history ↓Signals
Website registeredApr 9, 2015 (11 years old)
Funding rounds
- Series A · $82MSource: BioXconomy
- Website created
Founders and team
JG
Joshua Grass CEO & Co-FounderLH
Lalarukh Haris Shaikh Co-founder & Chief Technology OfficerJA
Jeff Ajer Chief Commercial Officer
Investors
Companies like Mendra
GGolden Age HealthSeed · Oct 2026
CCivic Roundtable$5M Seed · Feb 2024
MMythical Games$37M Series B+ · Jun 2023
KKeeboSeries A · Jul 2026
CCombocurve$50M Series B+ · Apr 2022
CCoultreon$125M Series A · Apr 2026
Other companies backed by 5AM Ventures
NNouscom$135.04M Series B+ · Oct 2026
KKinaset Therapeutics$103M Series B+ · Jan 2026
GGlycoEra$130M Series B+ · May 2025
LLifordi ImmunotherapeuticsSeries A · Nov 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mendra (get a free API key).